ABSTRACT The cellular autophagy response induced by herpes simplex virus 1 (HSV-1) is countered by the viral ␥34.5 protein.
rounds and segregates cytosolic material (22, 23) . This matures to a double-membrane structure, the autophagosome, which in turn fuses with the lysosome leading to the enzymatic breakdown of its contents (24, 25) . Although autophagy is constitutive, the rate of autophagosome formation and autophagic flux is tightly controlled, with Beclin-1 as a major regulator (26, 27) . Autophagy also plays a key role in antigen processing for major histocompatibility complex (MHC) presentation, especially to CD4 ϩ T cells (28) , and this activity is critical in vivo for protection against HSV-2 and other pathogens (29) .
Modulation of autophagy is important for the virulence of many viruses, including HIV, hepatitis B and C, and Coxsackie B (30) (31) (32) (33) (34) (35) (36) , underscoring the importance of understanding the interplay between viruses and autophagy. HSV-1 mutants lacking ␥34.5 demonstrate a PKR-and eIF2␣ phosphorylationdependent reduction of long-lived proteins and reduced volume of autophagic vacuoles in infected fibroblasts and neurons (11, 37) . Control of autophagy by ␥34.5 is mediated not only by its manipulation of eIF2␣ phosphorylation but also by its capacity to bind Beclin-1 through a 20-amino-acid Beclin-binding domain (BBD) in both mouse and human cells (38) . Mutants lacking BBD (⌬BBD) induce increased numbers of autophagosomes in epithelial cells and are neuro-attenuated in vivo (38) . This attenuation of the ⌬BBD mutant is dependent upon a functional adaptive immune response, and ⌬BBD mutant-infected mice display higher CD4 ϩ T cell responsiveness than mice infected with wild-type virus (39) . These observations suggested a possible role for ␥34.5 in modulation of the immune response via preclusion of autophagy in antigen-presenting cells (APCs). Emerging data, however, has suggested that the effect of ␥34.5 on autophagy in professional APCs may differ from that observed in fibroblasts or neurons. In infected macrophages, ␥34.5 leads to the formation of morphologically distinct autophagosomes that are associated with the nuclear envelope, and infected cells retain the ability to prime CD8 ϩ T cells (40) . Also, in contrast to neurons and fibroblasts, ␥34.5 does not inhibit the induction of autophagy in dendritic cells (DCs) (41) . Finally, the maturation of infected DCs is inhibited by ␥34.5 expression, further illustrating that ␥34.5 manipulates immune surveillance through multiple mechanisms (42) (43) (44) .
In this study, we wished to address the role of the BBD of ␥34.5 in alteration of the autophagy pathway in DCs. We also sought to study the functional consequences of ␥34.5 expression in these cells and to test whether ␥34.5 alone was sufficient for alteration of autophagy and T cell responses to presented antigen. To address this, we infected DCs with wild-type or mutant viruses and examined their capacity to form autophagosomes and process longlived proteins. We also constructed DC lines stably expressing ␥34.5 or its ⌬BBD mutant to examine their roles in modulation of autophagy in the absence of expression of other HSV genes. Our results showed that ␥34.5 does not prevent the induction of autophagy in DCs but rather prevents the maturation of autophagosomes. Significantly, we also illustrated a ␥34.5-and BBDdependent interference with the ability of DCs to stimulate antigen-specific T cells. These data suggest an important role for the BBD of ␥34.5 in the modulation of autophagy in DCs and genesis of the adaptive immune response.
RESULTS

HSV-1 infection induces autophagosome accumulation in infected DC2.4 cells. The conversion of LC3-I to its
phosphatidylethanolamine-conjugated form, LC3-II, is requisite for the formation of the autophagosome and is a widely used measurement of autophagy (45) . When DC2.4 cells were infected with the wild type (WT), the LC3-I isoform (top band) was reduced and LC3-II concentrations were~6-fold higher than in uninfected cells and significantly higher than observed in cells infected with ⌬␥34.5 and ⌬BBD mutants (Fig. 1A and B) . We hypothesized that this unexpected increased conversion of LC3 was indicative of Error bars indicate standard deviations between visualized fields. **, P Ͻ 0.005; ***, P Ͻ 0.001 (t test).
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increased autophagy and sought to assess this further by immunofluorescence microscopy. DC2.4 cells were infected with the WT, ⌬␥34.5, or ⌬BBD strain and analyzed 8 h postinfection. As a positive control, cells were treated with bafilomycin, which causes an accumulation of autophagosomes by preventing lysosome acidification (46, 47) . We observed a significant increase of LC3 puncta in WT-infected cells that was similar to levels seen following bafilomycin treatment (Fig. 1C and D) . In contrast, infection with the ⌬␥34.5 or ⌬BBD mutant did not result in an increase in LC3 puncta. In these experiments, cells scored as positive for autophagy contained from 20 to 60 puncta, whereas negative cells contained 0 to 3 puncta. Uninfected bystander cells, unstained for ICP8, did not accumulate LC3-specific puncta, indicating that the effect is dependent upon direct infection. Based on these results, we conclude that infection with wild-type virus, but not the ⌬␥34.5 or ⌬BBD mutant, results in an increased number of LC3-II-positive autophagosomes in DCs.
Long-lived proteins accumulate in HSV-infected dendritic cells. While an increase in LC3 lipidation often results from increased initiation of autophagy, LC3-II can also accumulate due to interference with the maturation phase of autophagy. To differentiate between these possibilities, we examined the stability of the long-lived protein p62. p62 is primarily involved in clearing ubiquitinated proteins from the cell, and its degradation by autophagy renders it a suitable marker for autophagic flux (48, 49) . Western blots for p62 were performed on lysates from DC2.4 cells infected for 8 h with WT, ⌬␥34.5-null, or ⌬BBD strains ( Fig. 2A  and B ). DC2.4 is a cell line derived from mouse bone marrow, and in the inactive form of the cells, like the epidermal myeloidderived DCs infected by HSV in vivo, they are poorly inflammatory and express little MHC class II (MHC-II), CD40, and CD80 (44, 50, 51) . They are phagocytosis-competent and mature when activated, upregulating MHC-II, CD40, and CD80 and secreting a wide variety of proinflammatory cytokines and chemokines. Cells infected with the WT had greater concentrations of p62 than uninfected cells or cells infected with the ⌬␥34.5 or ⌬BBD mutant, indicating that HSV interferes with catabolic breakdown of p62 in a BBD-dependent manner. These data are consistent with the hypothesis that the increased number of autophagosomes in HSVinfected dendritic cells is due to a BBD-dependent interference with the maturation phase of autophagy, analogous to the activities of influenza A M2 and HIV-1 Nef (30, 31) . To test this hypothesis further, we performed immunofluorescence microscopy for p62, with the prediction that we would see a greater number of p62-containing puncta in WT-infected cells than in cells infected with the ⌬␥34.5 and ⌬BBD mutants ( Fig. 2C and D) . Untreated cells showed p62 in a diffuse cytoplasmic pattern, in contrast to cells treated with bafilomycin, where distinct multiple cytoplasmic puncta were observed in the majority of cells. Consistent with our prediction, infection of DC2.4 with WT caused a significant accumulation of cytoplasmic puncta compared to that of mockinfected cells. In contrast ⌬␥34.5 or ⌬BBD mutant-infected cells did not significantly differ from mock-infected cells. Taken together, these data suggest that ␥34.5, through its BBD, prevents the maturation of autophagosomes, leading to the intracellular accumulation of p62.
Stably transduced DC2.4 lines express functional ␥34.5. Having shown that the BBD of ␥34.5 was necessary for impacting autophagy maturation in DCs, we next sought to determine whether ␥34.5 is sufficient for this function and whether the BBD is necessary. To examine this, we used a lentivirus expression vector to create ␥34.5-and ␥34.5⌬BBD mutant-expressing DC2.4 cell lines. Probing cell lysates from the stably transduced DC2.4 lines by Western blotting showed ␥34.5-and ␥34.5⌬BBD mutantreactive bands with the expected migration patterns (data not shown). To determine if the expressed proteins were functional in an autophagy-independent manner, we used Western blotting to test the levels of phosphorylated eIF2␣ induced by HSV-1 or poly(I:C) treatment (Fig. 3A) . ⌬␥34.5 infection was used to avoid the interfering effects of ␥34.5 being expressed by both the infected cells and the incoming virus. Both ⌬␥34.5 infection and poly(I:C) treatment strongly induced a band detectable by an eIF2␣ serine-51 phosphorylation-specific antibody in lysates from control cells but not in cells expressing full-length ␥34.5 or the ␥34.5⌬BBD mutant. These results demonstrated that the stably transduced DCs were expressing ␥34.5 and ␥34.5⌬BBD proteins that were equally capable of mediating the dephosphorylation of eIF2␣.
DC2.4 cells expressing ␥34.5 exhibit altered autophagy patterns. We next sought to determine if the stably transduced DC2.4 lines expressing ␥34.5 or the ␥34.5⌬BBD mutant exhibit altered patterns of autophagy ( Fig. 3B and C) . We stained stably transduced DC2.4 with an LC3-specific antibody and quantified cells per field with 4 or more puncta by immunofluorescence microscopy. Relative to control cells, we observed a significant increase in the number of cells with Ն4 LC3-positive puncta in the line expressing ␥34.5 but not in the control or ␥34.5⌬BBD mutant lines. All cell lines treated with bafilomycin displayed an expected increase in the number of LC3-specific puncta, showing that the pathways for induction of LC3-II were intact in all 3 cell lines. Based on these results, we conclude that ␥34.5 is sufficient to cause an increase in accumulation of LC3 puncta and that the changes in autophagy observed during infection of DCs with HSV are due largely to the activities of ␥34.5 and the BBD.
␥34.5 reduces cell survival following starvation and interferes with autophagic flux. Autophagy is induced in cells in response to starvation, thereby making biosynthetic precursors available to starving cells to preclude nutritional crisis and apoptosis. Cells with functional autophagy can therefore survive brief starvation stress, while cells deficient in autophagy are less resistant (52) (53) (54) . We utilized this classic observation to ask whether cells expressing wild-type ␥34.5 are less able to survive starvation relative to cells expressing the ␥34.5⌬BBD strain, thereby demonstrating a block to functional autophagy and survival. To assess this, cells were stained for the apoptosis marker annexin V during normal culture conditions and following starvation (Fig. 4A ). All cell lines stained equivalently for annexin V under normal culture conditions, but following a 2-h starvation, DC2.4 lines expressing ␥34.5, but not control cells or cells expressing the ␥34.5⌬BBD strain, had significantly increased annexin V staining. Cell viability, as measured by propidium iodide incorporation, was also reduced in starved cells expressing ␥34.5 (data not shown). These results indicate that despite ␥34.5-induced LC3-II positive puncta, autophagy-derived catabolites are not available for de novo biosynthesis under nutritional stress conditions, consistent with the idea that ␥34.5 inhibits the maturation phase of autophagy. To examine this further, we measured autophagic flux by examining p62 concentrations in each of the 3 cell lines in the presence and absence of bafilomycin ( Fig. 4B and C) . Untreated ␥34.5-expresssing cells exhibit higher concentrations of p62 than 
control cells or cells expressing the ␥34.5⌬BBD strain, relative to expression of ␣-tubulin. Bafilomycin treatment leads to an accumulation of p62 in all cells, showing that the pathways that promote p62 accumulation are intact in all cells. We infer from these data that autophagic flux is reduced by ␥34.5 and that this activity is dependent upon binding of Beclin-1.
Autophagy modulation by ␥34.5 in DCs interferes with T cell stimulation. Autophagy is involved in the presentation of intracellular antigens on MHC-II via its delivery of cytoplasmic components to the lysosome and multivesicular MHC-II-loading compartment (28) . We hypothesized that ␥34.5, by virtue of interfering with autophagic delivery of intracellular antigens to the lysosome, would prevent the presentation of intracellular antigens when expressed in DCs. To this end, we engineered a ␥34.5-deficient virus that expressed a truncated form of ovalbumin (OVA) lacking its amino-terminal signal sequence (virus termed ⌬␥34.5tOVA). Truncated OVA is not secreted and accumulates in the cytoplasm (55, 56) . This makes it an attractive tool for immunological analysis of intracellular antigen processing by autophagy. We used ⌬␥34.5tOVA in conjunction with OT-II T cell receptor transgenic mice. OT-II mice have CD4 ϩ T cells specific to the MHC-II immunodominant chicken ovalbumin peptide (residues 323 to 339) (57, 58) . We infected control DC2.4 lines or the stably transduced lines expressing ␥34.5 or the ␥34.5⌬BBD mutant with the ⌬␥34.5tOVA strain and examined their ability to present intracellular antigen by coculturing them with splenocytes from OT-II mice. We measured the percentage of responding CD4 ϩ T cells with a high degree of CD44 surface expression to quantify antigen exposure (Fig. 5) . High-CD44 populations were robustly induced in OT-II CD4 ϩ cells responding to the infected control DC line and to the cells expressing the ␥34.5⌬BBD strain. In marked contrast, the ␥34.5-expressing cell line infected with the ⌬␥34.5tOVA strain did not stimulate OT-II cells. These differences were due to the presence or absence of the BBD and independent of the remainder of the ␥34. ® type can therefore be primarily attributed to ␥34.5's effects upon the autophagic pathway. This T cell stimulation was antigen specific since CD44 surface expression was not upregulated in response to mock infection or infection with ⌬␥34.5 HSV-1 that lacked ovalbumin (Fig. 5B) . In addition, no stimulation was observed when infected DCs were cocultured with splenocytes from nontransgenic C57BL/6 mice (data not shown). With all cocultures, treatment with phorbol myristate acetate (PMA) and ionomycin increased CD44 surface expression in CD4 ϩ OT-II splenocytes, demonstrating that the T cells were responsive regardless of the DC lines in the coculture. We therefore conclude that ␥34.5 manipulates autophagosome maturation in DCs, via Beclin-1 interaction, resulting in functional interference with immune surveillance of intracellular antigens.
DISCUSSION
Data from a number of laboratories have suggested that ␥34.5 modulates autophagy during infection of fibroblasts and neurons via two activities, binding to Beclin-1 and dephosphorylation of eIF2␣ (11, 37, 38) . These data were consistent with the idea that autophagy is dependent on Beclin-1 and on the activities of PKR, whose principle target is eIF2␣. Two recent studies, however, have suggested that this model may be too simplistic, since the effect of ␥34.5 on autophagy appears to be cell type specific. First, and consistent with the data in this study, induction of autophagosomes in murine myeloid cells is not antagonized by ␥34.5 (41) . Second, a recent study showed that HSV-1 induces incomplete/ abortive autophagy in infected neuroblastoma cells (59) . These latter results differ from those which examined infected primary neurons in culture (37, 38) . This discordance may result from differences in autophagy pathways in immortalized SK-N-SH cells relative to postmitotic neurons or may simply reflect differences between human and mouse cells. The key question, however, is why do HSV-induced autophagy patterns differ so markedly in different cell types? Cell permissivity has been invoked as a possible explanation for the differences between DCs and fibroblasts (41) , although this cannot be the entire explanation, since primary DCs and neurons are both poorly permissive for productive HSV-1 infection yet markedly differ in their autophagy responses. Another key question is do different autophagy patterns confer any advantage for HSV as a pathogen? It is possible that following infection of certain cells (e.g., fibroblasts), HSV has evolved to evade xenophagy, whereas in others (e.g., APCs), HSV has evolved to minimize antigen presentation, to sequester pathogenassociated molecular patterns (PAMPs) in autophagosomes, or possibly to regulate the inflammasome (60) . It is also likely that other effects of ␥34.5 on DCs, such as the prevention of DC maturation (42) (43) (44) , impact the manner in which autophagy is inhibited by ␥34.5 in these unique cells. Cell-specific differential use of autophagy-related proteins, due to their shared use in phagocytosis, antigen presentation, or immune modulation (61) (62) (63) , may cause invading pathogens to evolve alternative strategies to subvert autophagy in different cell types. While evidence from our laboratory suggests that ␥34.5 does not modulate phagocytosis in DCs (P. A. M. Gobeil and D. A. Leib, unpublished data), this is clearly an important area that warrants further investigation.
The initial observation of a role for ␥34.5 in regulating MHC-II-restricted antigen presentation was described 10 years ago (64) . Work from our lab and others has served to show a role for ␥34.5 in controlling immunity through modulation of autophagy and APC maturation which underscores the multifunctional nature of ␥34.5's role in controlling immunity (42, 43, 65) . The maturation of DCs is dependent upon NF-B activation (66) , which can be suppressed through ␥34.5's regulation of IKK␤ activity (43) . Intriguingly, the posttranslational modification of IKK␤ is also important for the control of autophagy, so it is possible that this is yet another way in which ␥34.5 modulates the formation or maturation of autophagosomes (67) . Abortive autophagy, as observed in this study, occurs following infection with other viruses (e.g., hepatitis B and C, coxsackievirus B, and influenza) in a wide variety of cell types (31) (32) (33) (34) (35) (36) 68) . A close functional analog to ␥34.5 is HIV Nef, which can bind Beclin-1 and blocks virus-induced autophagosome maturation, causing accumulation of long-lived proteins, lipidated LC3, and autophagosomes in infected macrophages (30) . The lack of sequence similarity between ␥34.5 and HIV Nef, as well as between other viral modulators of autophagy, suggests that these genes and their functions have evolved independently. This mode of evolution highlights the common importance of this pathway in controlling virulence and development of innate and adaptive immunity.
During the revision of this report, TBK-1 was shown to be necessary for the maturation of autophagosomes (69) . TBK-1 inhibition leads to the accumulation of both LC3-II and p62 in a manner comparable to bafilomycin treatment and to the effects of ␥34.5 described herein. This is especially of interest given that ␥34.5 possesses a TBK-1 binding domain which partially overlaps the BBD (10). It could be argued, therefore, that mutagenesis of the BBD may have caused a defect in the ability of ␥34.5 to modulate TBK-1 in addition to ablation of Beclin binding. While this is a possibility, the virulence of a virus lacking BBD remained attenuated in mice lacking IRF-3 (39) . Given that TBK is critical for activation of IRF-3, we would have expected significantly increased virulence in these mice if the BBD-deleted virus was completely incapable of modulating TBK-1. This is an aspect of ␥34.5 function that clearly warrants closer scrutiny.
In conclusion, we have shown in this study that ␥34.5 is sufficient for control of autophagy in DCs and that the BBD of ␥34.5 is necessary for this control. In contrast to its activities in other cells, ␥34.5 allows autophagosomes to accumulate but interrupts autophagic degradation of long-lived proteins in DCs, significantly affecting presentation of intracellular antigens. This finding is important for enhancing our understanding of how adaptive immunity develops to HSV and how ␥34.5 can facilitate evasion of both innate and adaptive immunity. Currently, we are addressing the role of autophagy control in APCs during HSV-1 infection in vivo and investigating the DC-specific mechanisms that result in this atypical mode of manipulation of autophagy by ␥34.5. This work will serve to further elucidate the immune-modulatory activities of HSV-1 with impact on vaccine development and antitumor therapies using HSV as an oncolytic vector.
MATERIALS AND METHODS
Cells, viruses, and mice. BMDCs were generated and infected as previously described (70) . DC2.4 cells are BMDC-derived immortalized cell lines made available by Kenneth Rock (University of Massachusetts, Worcester, MA) and kindly provided by Ed Usherwood (Dartmouth) (50) . All infection protocols for DC2.4 cells were as previously described for BMDCs (71) . The DC2.4-derived stably transduced cells were made using the Clontech Lenti-X system. Briefly, ␥34.5 or ⌬34.5⌬BBD gene sequences were cloned into pLVX-IRES-Hyg vectors by digestion of pc␥34.5 and pc␥34.5⌬BBD expression vectors (72) with Sau3AI and XbaI (New England Biolabs) and of the lentiviral vector with BamHI and XbaI, thus placing the chicken beta-actin promoter upstream of ␥34.5 in the vector. New pLVX-␥34.5 and pLVX-␥34.5dBBD or control pLVX-IRESHyg vectors were then transfected into 293 Lenti-X cells along with helper plasmid according to the manufacturer's protocol. The lentiviruses produced were then used to transduce DC2.4 cells. Stable clones were isolated using 250 g/ml hygromycin. Expressing clones were identified by Western blotting and routinely propagated in hygromycin at a concentration of 100 to 300 g/ml to ensure stability. HSV-1 strain 17 (WT) was the background for all viruses in this study. The ␥34.5-null mutant, ⌬␥34.5, and the Beclin-binding domain mutant, ⌬BBD, were made as previously described (40, 72) . HSV-1 strain 17 ⌬34.5 tOVA was made using a truncated cytoplasmic-retained chicken ovalbumin (OVA)-encoding plasmid generously supplied by Charles Sentman (Dartmouth) (73) . The sequence was cloned into pCI using EcoRI and XhoI/SalI digests. The promoter and gene sequences from the resulting plasmid, pCI-tOVA, were transferred into the pUIC17 vector using BamHI/BglII cutting. This vector possesses a sequence from the UL49 and UL50 genes of strain 17 separated by a BglII restriction site (74) . The pUIC17-tOVA vector was cotransfected into Vero cells with ⌬␥34.5 infectious DNA to make strain 17 ⌬␥34.5 tOVA by homologous recombination as previously described (75) . Viruses were screened by PCR and Western blotting for expression of truncated OVA (data not shown). OT-II mice, originally developed by Francis Carbone (57), were generously provided by Ed Usherwood (Dartmouth).
Fluorescence microscopy. Cells were plated on glass coverslips and infected at the indicated multiplicities of infection (MOIs) for 8 or 16 h. Where applied, 100 M bafilomycin A 1 was added for 6 h. All samples were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 20 min at room temperature, blocked, and permeabilized in 2% goat serum (Vector Laboratories), 1% bovine serum albumen (BSA) (Sigma), 0.1% cold fish gelatin (Sigma), 0.1% Triton X-100 (Sigma) in PBS, pH 7.2, for 20 min. Primary and secondary antibodies were sequentially added, diluted in 5% goat serum in PBS. Coverslips were mounted using Vectashield mounting medium (Vector Laboratories). Antibodies used were specific to LC3 (1:400) (MBL PD014), p62 (1:1,000) (Novus NBP1-48320), ICP0 (1:1,500) (Virusys, HA027), or ICP8 (1:700) (kindly provided by David Knipe, Harvard Medical School). Microscopy was performed on a Zeiss AX10 microscope fitted with a QImaging cooled mono 14-bit camera. Images were captured at either ϫ66 magnification for puncta quantification or ϫ100 magnification for the images shown in this study. Equivalent contrast enhancement was applied to all images using Q-Capture Pro software.
When quantifying populations accumulating p62 or LC3 puncta, antibody-positive puncta were counted, and those with a minimum of 4 (LC3) or 5 (p62) puncta per cell were scored positive (76) . Total cell population, for determining ratios, were derived by counting DAPI (4=,6-diamidino-2-phenylindole)-positive nuclei, and infected cell populations were determined by counting nuclei costaining for ICP8 or ICP0. All fluorescence ratios were determined by imaging four or more fields and counting a minimum of 60 cells.
Western blotting. LC3 conversion and p62 accumulation assays were performed on DCs and BMDCs at an MOI of 8. Cells were infected for 8 or 16 h and treated with bafilomycin as described for fluorescence microscopy. Stable cells were induced to phosphorylate eIF2␣ using poly(I:C) at a concentration of 20 g/ml or infected with the ⌬␥34.5 strain, at an MOI of 8 for 12 h. Cell lysate was prepared by rinsing cells in PBS and resuspending them in sample buffer (62.5 mM Tris [lsqb]pH 6.8[rsqb], 4.65% SDS, 20% glycerol, 10% ␤-mercaptoethanol, 0.025% bromophenol blue) (Sigma). Membranes were probed with rabbit polyclonal anti LC3 (MBL PD014) or p62 (Novus NBP1-48320) using antibody concentrations of 1:1,000 and anti-␣-tubulin antibody (Novus NB100-690) as a loading control at 1:2,000. Anti-phospho-eIF2␣ (BioSource, AH01182) antibodies were used at 1:800, and anti-␥34.5 antibodies (a generous gift from Ian Mohr, New York University) were used at 1:1,000. Secondary goat-antirabbit or mouse horseradish peroxidase antibodies (Bio-Rad) were used in conjunction with ECL Western blotting substrate (Thermo) and detected on an Alpha Innotech Fluor Chem Q multi-imager. The molecular weights (MW) of bands of interest were determined by interpolation from MW 15.3 to 101.4 (Bio-Rad). Images were captured, molecular weights were determined, contrast was optimized, and band density was quantified using AlphaImager software. All blots are representative of a minimum of two experiments.
Starvation/survival assay. Cells were starved by replacing media with Earl's balanced salt solution for 2 h. Cells were then analyzed for cell viability by propidium iodide and Alexa Fluor 647-annexin V (BioLegend) staining according to the manufacturer's protocol. Flow cytometry and data analysis were performed on an Accuri flow cytometer (BD Biosciences).
T cell response assay and flow cytometry. Stably transduced DC2.4 cells were mock infected or infected with the 17 ⌬34.5 or 17 ⌬34.5 tOva strains at an MOI of 8.0, incubated for 1 h, and rinsed three times in Hank's balanced salt solution (HBSS). Whole OT-II splenocytes were then added at a ratio of 4 splenocytes to 1 DC. For positive controls, PMA and ionomycin were added at concentrations of 10 ng/ml and 1 g/ml, respectively. The coculture was incubated for 44 h, and cells were harvested for analysis by flow cytometry using anti-CD4-PercP and anti-CD44-FITC antibodies (Biolegends). Cells were gated based on the high surface expression of CD4, and gated cells were analyzed for high surface expression of CD44. All flow cytometry and analysis were performed on a BD Accuri C6 using CFlow software. Relative high-CD44 staining was expressed as a ratio relative to mock-infected cells.
